top of page
DSC_2149_edited.jpg

Earlier News: 2020

We help inventions grow!

Nanofibers from Technical University of Liberec brings new hope in fight against Covid-19

Enantis – first biotechnology spin-off from Masaryk University in Brno

DIANA Biotechnologies – technology that raised EUR 3M in 3 years

License for use of iBodies® bought by Immunotech, a member of the Beckman Coulter group!

LAM-X: revolutionary wound-treating nanomaterials

Elphogene – liquid biopsy assay for non-invasive monitoring of patients with colorectal cancer

LAM-X – light-activated nanomaterials for face-masks and respirators

Elphogene: non-invasive screening of patients in advanced stages of cancer

DRACEN Pharmaceuticals – Novel glutamine antagonist as anticancer therapies

iBodies – synthetic antibodies from Institute of Organic Chemistry and Biochemistry of the CAS

Elphogene in World Journal of Gastroenterology!

Prague startup RIOCATH had recently entered market with its world-unique catheter!

Czech anti-covid19 #hackathon won by two i&i Prague accelerated projects

LAM-X a.s. is collaborating with TUL to develop active nanofilters against COVID-19

iBodies established cooperation with Ximbio, a TTO within the UK’s largest charity, Cancer Research UK

LAM-X: the spin-off accelerated by i&i Prague in Media

bottom of page